Could Irisin Levels be Affected by Physical Activity in Patients with Schizophrenia?
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objective: The aim of this study was to explore the effect of physical activity and metabolic parameters on irisin levels in patients with schizophrenia and healthy controls. Methods: Ninety-six patients with schizophrenia and 63 healthy controls comprised the study population. The participants were separated into three groups: inactive, low activity, and sufficiently active according to International Physical Activity Questionnaire short form (IPAQ-SF). We measured irisin levels using Enzyme linked immunosorbent assay. We also calculated exercise levels by using the IPAQ-SF for each individual. The independent samples t test was used in the data analysis to compare irisin levels according to the activity levels of the patients with schizophrenia and controls. Results: The levels of irisin were higher in the healthy controls (p ＜ 0.001) compared to schizophrenia groups. When the activity levels of the schizophrenia and healthy control groups were compared, the irisin levels of the low activity and sufficiently active groups with schizophrenia were found to be lower than those of the low activity and sufficiently active groups in the healthy controls (respectively p = 0.014; p ＜ 0.001). Conclusion: Irisin levels could be affected by physical activity and these results must be supported with new studies.
Abstract
Objective: The aim of this study was to explore the effect of physical activity and metabolic parameters on irisin levels in patients with schizophrenia and healthy controls. Methods: Ninety-six patients with schizophrenia and 63 healthy controls comprised the study population. The participants were separated into three groups: inactive, low activity, and sufficiently active according to International Physical Activity Questionnaire short form (IPAQ-SF). We measured irisin levels using Enzyme linked immunosorbent assay. We also calculated exercise levels by using the IPAQ-SF for each individual. The independent samples t test was used in the data analysis to compare irisin levels according to the activity levels of the patients with schizophrenia and controls. Results: The levels of irisin were higher in the healthy controls (p ＜ 0.001) compared to schizophrenia groups. When the activity levels of the schizophrenia and healthy control groups were compared, the irisin levels of the low activity and sufficiently active groups with schizophrenia were found to be lower than those of the low activity and sufficiently active groups in the healthy controls (respectively p = 0.014; p ＜ 0.001). Conclusion: Irisin levels could be affected by physical activity and these results must be supported with new studies.
참고문헌 (29)
- Boström P, "A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis", Nature, 481, pp.463~468 (2012)
- Hecksteden A, "Irisin and exercise training in humans-results from a randomized controlled training trial", BMC Med, 11, pp.235~ (2013)
- Teufel A, "Frcp1 and Frcp2, two novel fibronectin type III repeat containing genes", Gene, 297, pp.79~83 (2002)
- Schumacher MA, "The structure of irisin reveals a novel intersubunit β-sheet fibronectin type III(FNIII)dimer : implications for receptor activation", J Biol Chem, 288, pp.33738~33744 (2013)
- Dun SL, "Irisin-immunoreactivity in neural and non-neural cells of the rodent", Neuroscience, 240, pp.155~162 (2013)
- Kim OY, "The role of irisin in Alzheimer's disease", J Clin Med, 7, pp.407~ (2018)
- Wrann CD, "Exercise induces hippocampal BDNF through a PGC-1α", FNDC5 pathway, 2013, pp.18, 649~659
- Moon HS, "Pharmacological concentrations of irisin increase cell proliferation without influencing markers of neurite outgrowth and synaptogenesis in mouse H19-7 hippocampal cell lines", Metabolism, 62, pp.1131~1136 (2013)
- Ostadsharif M, "The expression of peroxisomal protein transcripts increased by retinoic acid during neural differentiation", Differentiation, 81, pp.127~132 (2011)
- Jung KH, "Granulocyte colony-stimulating factor stimulates neurogenesis via vascular endothelial growth factor with STAT activation", Brain Res, 1073-1074, pp.190~201 (2006)
- Li DJ, "The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1", 2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia, 2017, pp.68, 31~42
- So JH, "Corrigendum : Intense exercise promotes adult hippocampal neurogenesis but not spatial discrimination", Front Cell Neurosci, 13, pp.303~ (2019)
- Craig CL, "International physical activity questionnaire : 12-country reliability and validity", Med Sci Sports Exerc, 35, pp.1381~1395 (2003)
- Saglam M, "International physical activity questionnaire : reliability and validity of the Turkish version", Percept Mot Skills, 111, pp.278~284 (2010)
- Overall JE, "The brief psychiatric rating scale", Psychol Rep, 10, pp.799~812 (1962)
- Soykan C, "Institutional differences and case typicality as related to diagnosis system severity, prognosis and treatment", pp.1990
- Erzin G, "Assessment of irisin, adiponectin and leptin levels in patients with schizophrenia", Endocr Metab Immune Disord Drug Targets, 18, pp.163~169 (2018)
- "Zhonghua Yi Xue Za Zhi", 2019, 520~524
- Zhu D, "Irisin improves endothelial function in type 2 diabetes through reducing oxidative", nitrative stresses, 2015, pp.87, 138~147
- Lu J, "Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice", Atherosclerosis, 243, pp.438~448 (2015)
- Kim S, "Roles of myokines in exercise-induced improvement of neuropsychiatric function", Pflugers Arch, 471, pp.491~505 (2019)
- Dinas PC, "Effects of physical activity on the link between PGC-1a and FNDC5 in muscle, circulating Irisin and UCP1 of white adipocytes in humans : a systematic review", F1000Res, 6, pp.286~ (2017)
- Tu WJ, "Decreased level of irisin, a skeletal muscle cell-derived myokine, is associated with post-stroke depression in the ischemic stroke population", J Neuroinflammation, 15, pp.133~ (2018)
- Tabak O, "The relationship between circulating irisin, retinol binding protein-4, adiponectin and inflammatory mediators in patients with metabolic syndrome", Arch Endocrinol Metab, 61, pp.515~523 (2017)
- Askari H, "A glance at the therapeutic potential of irisin against diseases involving inflammation, oxidative stress, and apoptosis : an introductory review", Pharmacol Res, 129, pp.44~55 (2018)
- Gaggini M, "Increased FNDC5", Irisin expression in human hepatocellular carcinoma, 2017, pp.88, 62~66
- Choi SH, "Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer's mouse model", Science, 361, pp.eaan8821~ (2018)
- Martínez-Gras I, "The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia", Schizophr Res, 128, pp.15~22 (2011)
- Green MJ, "Brain-derived neurotrophic factor levels in schizophrenia : a systematic review with meta-analysis", Mol Psychiatry, 16, pp.960~972 (2011)